Radiology outpatients’ awareness of their out-of-pocket estimates and hospital price estimator tools in the United States

IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES
Jasmine Kaur Dhillon , Desiree Anderson , Thuan Gia-Nhat Tran , Arham Aijaz , Ruth C. Carlos , Gelareh Sadigh
{"title":"Radiology outpatients’ awareness of their out-of-pocket estimates and hospital price estimator tools in the United States","authors":"Jasmine Kaur Dhillon ,&nbsp;Desiree Anderson ,&nbsp;Thuan Gia-Nhat Tran ,&nbsp;Arham Aijaz ,&nbsp;Ruth C. Carlos ,&nbsp;Gelareh Sadigh","doi":"10.1016/j.hlpt.2024.100902","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Price transparency mandates by the Centers for Medicare and Medicaid Services (CMS) were implemented in 2021 for hospitals and 2023 for health plans. We assessed U.S. patients’ awareness of their estimated out-of-pocket cost (OOPC) and hospital price-estimator tool among outpatients undergoing advanced imaging.</p></div><div><h3>Methods</h3><p>English-, Spanish-, and Vietnamese-speaking adults receiving a CT, PET/CT, or MRI at a tertiary academic center between 11/2022 and 03/2023 completed a 15-minute survey. We assessed awareness of OOPC estimates prior to imaging and the hospital price-estimator tool, and factors associated with such awareness using multivariable regression analysis.</p></div><div><h3>Results</h3><p>423 patients were included (mean age: 57.1 ± 15.6; 57.4 % female; 55 % White; 21.8 % Hispanic; 18.9 % Asian). Only 10.7 % and 16.8 % were aware of their OOPC before receipt of imaging and center'shospital price-estimator tool, respectively. No patient used the hospital price estimator tool to obtain their OOPC estimate. Annual household income of $50,000 or more (OR: 30.25, 95 % CI: 1.78, 513.79), and having at least one comorbidity (OR: 4.59, 95 % CI: 1.42, 14.79) were associated with a higher probability of knowing OOPC prior to imaging. Patients who experienced financial hardship were less likely to be aware of their OOPC (OR: 0.29, CI: 0.10, 0.86). No significant factors were associated with awareness of hospital price estimator tool in full regression model.</p></div><div><h3>Conclusion</h3><p>Our study highlights limited OOPC and price estimator tool awareness, two years post-CMS mandate, with specific demographics more likely to know their OOPC. Our findings emphasize the urgency for targeted interventions to increase price awareness and enhance healthcare decision-making.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 4","pages":"Article 100902"},"PeriodicalIF":3.4000,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883724000650/pdfft?md5=cc003f5c8f539e20b29f3eba4ac3774d&pid=1-s2.0-S2211883724000650-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211883724000650","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Price transparency mandates by the Centers for Medicare and Medicaid Services (CMS) were implemented in 2021 for hospitals and 2023 for health plans. We assessed U.S. patients’ awareness of their estimated out-of-pocket cost (OOPC) and hospital price-estimator tool among outpatients undergoing advanced imaging.

Methods

English-, Spanish-, and Vietnamese-speaking adults receiving a CT, PET/CT, or MRI at a tertiary academic center between 11/2022 and 03/2023 completed a 15-minute survey. We assessed awareness of OOPC estimates prior to imaging and the hospital price-estimator tool, and factors associated with such awareness using multivariable regression analysis.

Results

423 patients were included (mean age: 57.1 ± 15.6; 57.4 % female; 55 % White; 21.8 % Hispanic; 18.9 % Asian). Only 10.7 % and 16.8 % were aware of their OOPC before receipt of imaging and center'shospital price-estimator tool, respectively. No patient used the hospital price estimator tool to obtain their OOPC estimate. Annual household income of $50,000 or more (OR: 30.25, 95 % CI: 1.78, 513.79), and having at least one comorbidity (OR: 4.59, 95 % CI: 1.42, 14.79) were associated with a higher probability of knowing OOPC prior to imaging. Patients who experienced financial hardship were less likely to be aware of their OOPC (OR: 0.29, CI: 0.10, 0.86). No significant factors were associated with awareness of hospital price estimator tool in full regression model.

Conclusion

Our study highlights limited OOPC and price estimator tool awareness, two years post-CMS mandate, with specific demographics more likely to know their OOPC. Our findings emphasize the urgency for targeted interventions to increase price awareness and enhance healthcare decision-making.

美国放射科门诊患者对自费估算和医院价格估算工具的认识
目的 美国医疗保险和医疗补助服务中心(CMS)规定医院和医疗保险计划分别于 2021 年和 2023 年实行价格透明化。我们评估了接受高级成像检查的门诊患者中,美国患者对其预估自付费用(OOPC)和医院价格估算工具的认知情况。方法2022 年 11 月至 2023 年 3 月期间,在三级学术中心接受 CT、PET/CT 或 MRI 检查的讲英语、西班牙语和越南语的成年人完成了一项 15 分钟的调查。我们使用多变量回归分析评估了成像前对 OOPC 估算值和医院价格估算工具的了解程度,以及与了解程度相关的因素。结果共纳入 423 名患者(平均年龄:57.1 ± 15.6;女性占 57.4%;白人占 55%;西班牙裔占 21.8%;亚裔占 18.9%)。分别只有 10.7% 和 16.8% 的患者在接受造影检查和中心的医院价格估算工具之前知道自己的 OOPC。没有患者使用医院价格估算工具来估算其 OOPC。家庭年收入在 50,000 美元或以上(OR:30.25,95 % CI:1.78, 513.79)和至少患有一种并发症(OR:4.59,95 % CI:1.42, 14.79)的患者在接受造影检查前知道 OOPC 的可能性较高。经济困难的患者不太可能知道自己的 OOPC(OR:0.29,CI:0.10,0.86)。在完全回归模型中,没有明显的因素与医院价格估算工具的知晓率相关。结论:我们的研究表明,在 CMS 规定实施两年后,患者对 OOPC 和价格估算工具的知晓率有限,特定人群更有可能知晓自己的 OOPC。我们的研究结果表明,迫切需要采取有针对性的干预措施来提高人们对价格的认识并改善医疗决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Health Policy and Technology
Health Policy and Technology Medicine-Health Policy
CiteScore
9.20
自引率
3.30%
发文量
78
审稿时长
88 days
期刊介绍: Health Policy and Technology (HPT), is the official journal of the Fellowship of Postgraduate Medicine (FPM), a cross-disciplinary journal, which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments. HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology. Topics covered by HPT will include: - Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems - Cross-national comparisons on health policy using evidence-based approaches - National studies on health policy to determine the outcomes of technology-driven initiatives - Cross-border eHealth including health tourism - The digital divide in mobility, access and affordability of healthcare - Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies - Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies - Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making - Stakeholder engagement with health technologies (clinical and patient/citizen buy-in) - Regulation and health economics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信